Low dosis of alteplase, for ischemic stroke after Enchanted and its determinants, a single center experience

Abstract Background: Low-dose alteplase (LrtPA) has been shown not to be inferior to the standard-dose (SrtPA) with respect to death/disability. Objective: We aim to evaluate the percentage of patients treated with LrtPA at our center after the ENCHANTED trial and the factors associated with the u...

Full description

Bibliographic Details
Main Authors: Alejandro Michel Brunser, Enrico Mazzon, Gabriel Cavada, Eloy Mansilla, Alexis Rojo, Juan Almeida, Verónica Viviana Olavarría, Paula Muñoz-Venturelli, Pablo Manuel Lavados
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2020-12-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/pdf/anp/v78n11/1678-4227-anp-78-11-0681.pdf